These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33539195)

  • 21. A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
    Helmkamp LJ; Szilagyi PG; Zimet G; Saville AW; Gurfinkel D; Albertin C; Breck A; Vangala S; Kempe A
    Vaccine; 2021 Mar; 39(13):1831-1839. PubMed ID: 33676784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceived challenges in implementing halal standards by halal certifying bodies in the United States.
    Al-Mahmood OA; Fraser AM
    PLoS One; 2023; 18(8):e0290774. PubMed ID: 37651404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine hesitancy among people with multiple sclerosis.
    Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
    Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the development of influenza virus vaccines.
    Krammer F; Palese P
    Nat Rev Drug Discov; 2015 Mar; 14(3):167-82. PubMed ID: 25722244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
    Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
    Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza Virus: Dealing with a Drifting and Shifting Pathogen.
    Kim H; Webster RG; Webby RJ
    Viral Immunol; 2018 Mar; 31(2):174-183. PubMed ID: 29373086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. History and evolution of influenza control through vaccination: from the first monovalent vaccine to universal vaccines.
    Barberis I; Myles P; Ault SK; Bragazzi NL; Martini M
    J Prev Med Hyg; 2016 Sep; 57(3):E115-E120. PubMed ID: 27980374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of cell culture-based influenza vaccine production.
    Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
    Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of influenza vaccine hesitancy at a tertiary care hospital in Riyadh, Saudi Arabia.
    Alabbad AA; Alsaad AK; Al Shaalan MA; Alola S; Albanyan EA
    J Infect Public Health; 2018; 11(4):491-499. PubMed ID: 28988776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccines: a moving interdisciplinary field.
    Schotsaert M; García-Sastre A
    Viruses; 2014 Oct; 6(10):3809-26. PubMed ID: 25302957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The continuum of influenza vaccine hesitancy among nursing professionals in Hong Kong.
    Lau LHW; Lee SS; Wong NS
    Vaccine; 2020 Oct; 38(43):6785-6793. PubMed ID: 32891475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Halal pharmaceuticals: Views from outpatients in a Malaysian state hospital.
    Ang WC; Khadir NA; Lahazir NAS; Baharudin AH
    Med J Malaysia; 2024 Sep; 79(5):512-516. PubMed ID: 39352151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
    Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
    Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal influenza vaccines: Shifting to better vaccines.
    Berlanda Scorza F; Tsvetnitsky V; Donnelly JJ
    Vaccine; 2016 Jun; 34(26):2926-2933. PubMed ID: 27038130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seasonal influenza vaccination and technologies.
    Nafziger AN; Pratt DS
    J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus.
    Rajaram S; Wojcik R; Moore C; Ortiz de Lejarazu R; de Lusignan S; Montomoli E; Rossi A; Pérez-Rubio A; Trilla A; Baldo V; Jandhyala R; Kassianos G
    Vaccine; 2020 Aug; 38(38):6047-6056. PubMed ID: 32600916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selected problems of manufacturing influenza vaccines].
    Augustynowicz E
    Przegl Epidemiol; 2010; 64(3):373-80. PubMed ID: 20976949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.